Skip to content

Clinical trials

Psychotic Disorders trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Psychotic Disorders Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20101
20111
20121
20131
20142
20191
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Recruiting2
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Janssen Research & Development, LLC2
European Group for Research In Schizophrenia1
Janssen Cilag N.V./S.A.1
Karuna Therapeutics, Inc., a Bristol Myers Squibb company1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
PharmaNeuroBoost N.V.1
Rene Kahn1
UMC Utrecht1
Universitaire Ziekenhuizen KU Leuven1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Psychotic Disorders14
Schizophrenia11
Alzheimer Disease2
Bipolar Disorder2
Acute Disease1
Amyotrophic Lateral Sclerosis1
Cognitive Dysfunction1
Dementia1
Depressive Disorder1
Lewy Body Disease1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.